

Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery
Mar 14, 2022
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
Introduction
00:00 • 3min
Ray Stevens, Welcome to the Long Run
02:56 • 2min
What Was It Like Growing Up in Auburn, Main?
04:26 • 2min
Growing Up, What Do You Do for a Living?
06:04 • 2min
What Kind of Student Did You Be?
07:43 • 2min
University of Southern Maine
09:25 • 3min
How Did You Get Into Pharmacology?
12:24 • 3min
Aurkly, I'm a Chemist and I'd Like to Be an Independent Professor
15:34 • 3min
What Was So Difficult About GPC Rs?
18:25 • 3min
Do You Have Any Success With G Protin Coupled Receptors?
20:58 • 3min
Collaboration With Pete Scholtz Was Incredibly Productive
24:05 • 2min
What Kind of Skills Were You Surrounded by at Te Scrips?
26:05 • 2min
How Did You Become a Biotechnologist?
28:01 • 2min
What I Love About Starting Biote Companies
30:07 • 2min
The Long Run Podcast
31:52 • 2min
How Big of a Life Anger Was This for You as a Co-Founder?
33:45 • 3min
Is Small Molecule a Better Modality Than a Biologic?
36:46 • 2min
Drug Discovery Platform - What Are the Biggest Breakthroughs?
38:20 • 2min
Receptos Salgin's Not Going to Do Anything With This.
40:39 • 2min
How Did You See the Potential in China?
43:04 • 4min
You're No Longer a Professor at Us C
47:30 • 2min
How Much of the Language Do You Speak?
49:15 • 3min
How to Build Trust in a Bilateral Company?
52:19 • 4min
How to Get the Most Out of Your Intellectual Property
56:42 • 2min
Biotec - What's Next for Biotec?
58:56 • 2min
The Long Run, a Production Oftier and Report
01:00:54 • 2min